Abbott backs India’s drug patent regime

Times of India April 27, 2014
The [Indian] government has received support from an unexpected quarter in its battle against the US on the intellectual property (IP) regime.  Amid an uproar for action against India by Big Pharma, American drug major Abbott has told the US International Trade Commission (USITC) that it is “not currently facing any significant challenges with respect to intellectual property protection in India”.  Abbott is the second US company after Boeing to support India’s case, leaving companies such as Pfizer and Novartis as the top protesters who are demanding changes to the Indian IP regime,
…… read more here

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply